| Prostate Neoplasm studied in …STUDIED_INderived10 of 6,544show all (up to 200) |
|---|
| → studied in | NCT01230866Phase 3 · active not recruiting Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01492972Phase 3 · recruiting Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Prostate Small Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04736199Phase 3 · completed Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer · condition mapped ALIAS · 6,544 trials mapped (1,848 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081193Phase 2 · active not recruiting Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05148156NA · recruiting Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer. · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Benign Prostatic Hyperplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06011304Phase 3 · completed Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer · condition mapped CURATED_EXACT · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541210NA · recruiting Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men · condition mapped ONTOLOGY_EXACT · 6,544 trials mapped (1,848 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06738303Phase 2 · recruiting Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer · condition mapped CURATED_BROADER · 6,544 trials mapped (1,848 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |